Logo image
Can aspirin reduce the risk of hepatocellular carcinoma in cirrhosis: the AspiRe HCC trial
Conference presentation

Can aspirin reduce the risk of hepatocellular carcinoma in cirrhosis: the AspiRe HCC trial

Khurshid Alam
Australian Gastroenterology Week (AGW) 2026 (Perth, WA, 28/08/2026–31/08/2026)
08/2026

Details

Metrics

1 Record Views
Logo image